These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 9539866)
1. Differential myocardial abundance of collagen type I and type III mRNA in dilated cardiomyopathy: effects of myocardial inflammation. Pauschinger M; Doerner A; Remppis A; Tannhäuser R; Kühl U; Schultheiss HP Cardiovasc Res; 1998 Jan; 37(1):123-9. PubMed ID: 9539866 [TBL] [Abstract][Full Text] [Related]
2. [Detection of enteroviral RNA in endomyocardial biopsies in inflammatory cardiomyopathy and idiopathic dilated cardiomyopathy]. Pauschinger M; Kühl U; Dörner A; Schieferecke K; Petschauer S; Rauch U; Schwimmbeck PL; Kandolf R; Schultheiss HP Z Kardiol; 1998 Jun; 87(6):443-52. PubMed ID: 9691414 [TBL] [Abstract][Full Text] [Related]
3. Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Pauschinger M; Knopf D; Petschauer S; Doerner A; Poller W; Schwimmbeck PL; Kühl U; Schultheiss HP Circulation; 1999 Jun; 99(21):2750-6. PubMed ID: 10351968 [TBL] [Abstract][Full Text] [Related]
4. Collagen content, but not the ratios of collagen type III/I mRNAs, differs among hypertensive, alcoholic, and idiopathic dilated cardiomyopathy. Soufen HN; Salemi VM; Aneas IM; Ramires FJ; Benício AM; Benvenuti LA; Krieger JE; Mady C Braz J Med Biol Res; 2008 Dec; 41(12):1098-104. PubMed ID: 19148372 [TBL] [Abstract][Full Text] [Related]
5. Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy. Rubiś P; Wiśniowska-Śmialek S; Wypasek E; Biernacka-Fijalkowska B; Rudnicka-Sosin L; Dziewiecka E; Faltyn P; Khachatryan L; Karabinowska A; Kozanecki A; Tomkiewicz-Pająk L; Podolec P Inflamm Res; 2016 Dec; 65(12):941-949. PubMed ID: 27516211 [TBL] [Abstract][Full Text] [Related]
6. Endomyocardial miR-133a levels correlate with myocardial inflammation, improved left ventricular function, and clinical outcome in patients with inflammatory cardiomyopathy. Besler C; Urban D; Watzka S; Lang D; Rommel KP; Kandolf R; Klingel K; Thiele H; Linke A; Schuler G; Adams V; Lurz P Eur J Heart Fail; 2016 Dec; 18(12):1442-1451. PubMed ID: 27292200 [TBL] [Abstract][Full Text] [Related]
7. [Mechanisms of extracellular matrix remodeling in dilated cardiomyopathy]. Pauschinger M; Chandrasekharan K; Li J; Schwimmbeck PL; Noutsias M; Schultheiss HP Herz; 2002 Nov; 27(7):677-82. PubMed ID: 12439639 [TBL] [Abstract][Full Text] [Related]
8. Immunopathogenesis of dilated cardiomyopathy. Evidence for the role of TH2-type CD4+T lymphocytes and association with myocardial HLA-DR expression. Kuethe F; Braun RK; Foerster M; Schlenker Y; Sigusch HH; Kroegel C; Figulla HR J Clin Immunol; 2006 Jan; 26(1):33-9. PubMed ID: 16418801 [TBL] [Abstract][Full Text] [Related]
9. Myocardial osteopontin expression is associated with collagen fibrillogenesis in human dilated cardiomyopathy. Satoh M; Nakamura M; Akatsu T; Shimoda Y; Segawa I; Hiramori K Eur J Heart Fail; 2005 Aug; 7(5):755-62. PubMed ID: 16087132 [TBL] [Abstract][Full Text] [Related]
11. Laminin distribution and autoantibodies to laminin in dilated cardiomyopathy and myocarditis. Wolff PG; Kühl U; Schultheiss HP Am Heart J; 1989 Jun; 117(6):1303-9. PubMed ID: 2658521 [TBL] [Abstract][Full Text] [Related]
12. Immunohistological characterization of infiltrating lymphocytes in biopsies of patients with clinically suspected dilated cardiomyopathy. Kühl U; Seeberg B; Schultheiss HP; Strauer BE Eur Heart J; 1994 Aug; 15 Suppl C():62-7. PubMed ID: 7995272 [TBL] [Abstract][Full Text] [Related]
13. Assessment of the inflammatory process by endomyocardial biopsy in patients with dilated cardiomyopathy based on pathological and immunohistochemical methods. Prochorec-Sobieszek M; Bilińska ZT; Grzybowski J; Mazurkiewicz L; Skwarek M; Walczak E; Michalak E; Cedro K; Chmielak Z; Debski A; Demkow M; Witkowski A; Wagner T; Ruzyłło W Kardiol Pol; 2006 May; 64(5):479-87; discussion 488. PubMed ID: 16752331 [TBL] [Abstract][Full Text] [Related]
14. [Immune status of patients with cardiac arrhythmias: idiopathic and in primary heart disease]. Bekbosynova MS; Pichugin AV; Novikova DS; Gabrusenko SA; Kozhemiakina ESh; Ataullakhanova DM; Golitsyn SP; Ataullakhanov RI Ter Arkh; 2006; 78(9):52-60. PubMed ID: 17076226 [TBL] [Abstract][Full Text] [Related]
15. Increased gene expression of collagen Types I and III is inhibited by beta-receptor blockade in patients with dilated cardiomyopathy. Shigeyama J; Yasumura Y; Sakamoto A; Ishida Y; Fukutomi T; Itoh M; Miyatake K; Kitakaze M Eur Heart J; 2005 Dec; 26(24):2698-705. PubMed ID: 16204268 [TBL] [Abstract][Full Text] [Related]
17. [The expression of dystrophin in human viral myocarditis and dilated cardiomyopathy]. Xu HF; Li YH; Chen Y; Cheng LB Fa Yi Xue Za Zhi; 2006 Feb; 22(1):12-4. PubMed ID: 16524176 [TBL] [Abstract][Full Text] [Related]
18. Myocardial remodeling in viral heart disease: possible interactions between inflammatory mediators and MMP-TIMP system. Pauschinger M; Chandrasekharan K; Schultheiss HP Heart Fail Rev; 2004 Jan; 9(1):21-31. PubMed ID: 14739765 [TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of intramyocardial mesenchymal stem cells and VEGF165 plasmid injection in rats with furazolidone induced dilated cardiomyopathy. Yu Q; Fang W; Zhu N; Zheng X; Na R; Liu B; Meng L; Li Z; Li Q; Li X J Cell Mol Med; 2015 Aug; 19(8):1868-76. PubMed ID: 25753859 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemistry in dilated cardiomyopathy. Kühl U; Noutsias M; Schultheiss HP Eur Heart J; 1995 Dec; 16 Suppl O():100-6. PubMed ID: 8682073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]